⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

December 13, 2022Current OncologyOpen Access

Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma

View Full Paper

Ask AI

Bookmark

Share

Authors

SWStephanie WooGeorgetown University AKAlexandra V. KimchyGeorgetown University LSLynette M. SequeiraJohns Hopkins University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Woo et al. (2022) studied this question.

synapsesocial.com/papers/6a70acbde5469ee92be16158 https://doi.org/10.3390/curroncol29120771

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cancer immunotherapy: the beginning of the end of cancer?2016 · 1,217 citations
2Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma2011 · 576 citations
3PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma2021 · 76 citations
4Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases2018 · 4,690 citations
5Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors2021 · 42 citations